医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SHL Nominated for Financial Times Standard Chartered Taiwan Business Award for Economic Contribution

2014年07月07日 PM10:00
このエントリーをはてなブックマークに追加


 

TAIPEI, Taiwan

SHL, the world’s leader in designing, developing and manufacturing of auto injectors, was nominated as one of the 3 top companies in Taiwan for the FT-Standard Chartered Taiwan Business Award in the Economic Contribution category.

The Financial Times and Standard Chartered Taiwan first launched this award program in 2013 and received significant recognition for their efforts to highlight the various achievements of Taiwan companies and entrepreneurs. Areas of recognition include economic contribution, responsible business, entrepreneurial success and internationally visibility. A rigorous screening of the numerous submissions was held by a prestigious judging panel, resulting in a final shortlist of 3 companies in each category.

With more than 2,600 employees world-wide and 2,100 located in Taiwan, SHL currently works with 80% of the world’s top 25 biopharmaceutical companies, has more than 50 pipeline devices in the making and plans to invest in approximately 180 additional machines within the next 5 years to further enhance capacity. SHL demonstrated commitment to investing and expanding in Taiwan by signing a second Letter of Intent (LOI) with the Taiwan Ministry of Economic Affairs to invest an additional $40 million in Taiwan in 2013, a follow-up investment to the initial LOI signed in 2008 for a $100 million USD investment over five years, which was fulfilled by SHL within just four years.

In 2013 alone, SHL increased manpower by 18.2% in and continues to contribute significantly to its surrounding communities both socially and economically. SHL was shortlisted alongside two of Taiwan’s most significant companies – Taiwan Semiconductor Manufacturing Company Limited (TSMC) and Taiwan Mobile. Although TSMC was awarded as the final winner, SHL was honored to have been selected from amongst such a large pool of renowned candidates and to come out as one of the top 3.

Commenting on the event, SHL Group General Manager Frank Isaksson says, “We feel very privileged to be nominated for this award. Being one of the top 3 together with such iconic and well respected companies was a true accomplishment, especially since the winner TSMC contributes to 4% of Taiwan’s GDP. This also indicates that there’s still immense room for growth for SHL here in Taiwan and that is what we will continue to commit to.”

CONTACT

SHL Media Contact
Steven Kaufman, +886-32170303
Marketing
Director
pr@shl-group.com
www.shl-group.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表